162 related articles for article (PubMed ID: 22508544)
41. FGFR4: A promising therapeutic target for breast cancer and other solid tumors.
Levine KM; Ding K; Chen L; Oesterreich S
Pharmacol Ther; 2020 Oct; 214():107590. PubMed ID: 32492514
[TBL] [Abstract][Full Text] [Related]
42. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
[TBL] [Abstract][Full Text] [Related]
43. FGFR-targeted therapeutics for the treatment of breast cancer.
De Luca A; Frezzetti D; Gallo M; Normanno N
Expert Opin Investig Drugs; 2017 Mar; 26(3):303-311. PubMed ID: 28121208
[TBL] [Abstract][Full Text] [Related]
44. Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations.
Gallo LH; Nelson KN; Meyer AN; Donoghue DJ
Cytokine Growth Factor Rev; 2015 Aug; 26(4):425-49. PubMed ID: 26003532
[TBL] [Abstract][Full Text] [Related]
45. Fibroblast growth factor receptors in breast cancer.
Wang S; Ding Z
Tumour Biol; 2017 May; 39(5):1010428317698370. PubMed ID: 28459213
[TBL] [Abstract][Full Text] [Related]
46. Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.
Lang JE; Wecsler JS; Press MF; Tripathy D
J Surg Oncol; 2015 Jan; 111(1):81-90. PubMed ID: 25091830
[TBL] [Abstract][Full Text] [Related]
47. Targeting FGFR pathway in breast cancer.
Perez-Garcia J; Muñoz-Couselo E; Soberino J; Racca F; Cortes J
Breast; 2018 Feb; 37():126-133. PubMed ID: 29156384
[TBL] [Abstract][Full Text] [Related]
48. Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer.
Jain VK; Turner NC
Breast Cancer Res; 2012 Jun; 14(3):208. PubMed ID: 22731805
[TBL] [Abstract][Full Text] [Related]
49. Fibroblast growth factor receptors: multifactorial-contributors to tumor initiation and progression.
Feng S; Zhou L; Nice EC; Huang C
Histol Histopathol; 2015 Jan; 30(1):13-31. PubMed ID: 25053532
[TBL] [Abstract][Full Text] [Related]
50. [Developing FGFR inhibitors as potential anti-cancer agents].
Zsákai L; Németh G; Szántai-Kis C; Greff Z; Horváth Z; Szokol B; Baska F; Boon TC; Orfi L; Kéri G
Acta Pharm Hung; 2013; 83(2):47-56. PubMed ID: 23926649
[TBL] [Abstract][Full Text] [Related]
51. Role of Fibroblast Growth Factors Receptors (FGFRs) in Brain Tumors, Focus on Astrocytoma and Glioblastoma.
Ardizzone A; Scuderi SA; Giuffrida D; Colarossi C; Puglisi C; Campolo M; Cuzzocrea S; Esposito E; Paterniti I
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33352931
[TBL] [Abstract][Full Text] [Related]
52. Successes and limitations of targeted cancer therapy in breast cancer.
Curigliano G; Criscitiello C
Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
[TBL] [Abstract][Full Text] [Related]
53. Understanding the role of structural integrity and differential expression of integrin profiling to identify potential therapeutic targets in breast cancer.
Das V; Kalyan G; Hazra S; Pal M
J Cell Physiol; 2018 Jan; 233(1):168-185. PubMed ID: 28120356
[TBL] [Abstract][Full Text] [Related]
54. Metaplastic breast cancer: clinical overview and molecular aberrations for potential targeted therapy.
Abouharb S; Moulder S
Curr Oncol Rep; 2015 Mar; 17(3):431. PubMed ID: 25691085
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer.
Murase H; Inokuchi M; Takagi Y; Kato K; Kojima K; Sugihara K
Mol Clin Oncol; 2014 Jul; 2(4):509-517. PubMed ID: 24940486
[TBL] [Abstract][Full Text] [Related]
56. Mathematical modeling for novel cancer drug discovery and development.
Zhang P; Brusic V
Expert Opin Drug Discov; 2014 Oct; 9(10):1133-50. PubMed ID: 25062617
[TBL] [Abstract][Full Text] [Related]
57. The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments.
Navid S; Fan C; O Flores-Villanueva P; Generali D; Li Y
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188012
[TBL] [Abstract][Full Text] [Related]
58. Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer.
Sobhani N; Ianza A; D'Angelo A; Roviello G; Giudici F; Bortul M; Zanconati F; Bottin C; Generali D
Cells; 2018 Jul; 7(7):. PubMed ID: 30011957
[TBL] [Abstract][Full Text] [Related]
59. Drug discovery for breast cancer and co-instantaneous cardiovascular disease: what is the future?
Yin L; Hu Q
Future Med Chem; 2013 Mar; 5(4):359-62. PubMed ID: 23495679
[No Abstract] [Full Text] [Related]
60. From DNA binding to metabolic control: integration of -omics data reveals drug targets for prostate cancer.
Gao H; Dahlman-Wright K
EMBO J; 2011 Jul; 30(13):2516-7. PubMed ID: 21731047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
